AMST vs PN

AMST exhibits severe financial distress despite strong revenue growth, as reflected in its critically low Piotroski F-Score of 1/9 and absence of an Altman Z-Score, indicating high bankruptcy risk. The company reports massive operating losses, negative ROE and ROA, and a gross margin that is artificially inflated by minimal cost structure, suggesting unsustainable profitability. While revenue growth is explosive at 746.8% YoY, it is not translating into earnings, and the stock trades at an extreme valuation (Price/Sales: 27.71) with no earnings support. The 52-week price range shows extreme volatility, and the 5-year return of -97.4% underscores long-term underperformance. Analyst coverage is absent, and insider activity is neutral, offering no conviction signal.

PN exhibits a paradoxical profile: while the Piotroski F-Score of 5/9 suggests stable financial health and valuation multiples (P/B 0.21, P/S 0.13) are mathematically deep-value, the price action is catastrophic. The stock has collapsed over 93% in the last year, falling from a high of $87.40 to $3.13, indicating a severe loss of market confidence or potential fundamental impairment not yet reflected in the lagging accounting data. Despite strong YoY revenue growth of 42.9%, the company remains unprofitable with negative margins and a total lack of technical support.